Cystoprostatectomy Treatments for Men with Bladder Cancer in Orlando, FL
Men with bladder cancer in the Orlando, Florida, area who require a cystoprostatectomy will find world-class treatment options available at Moffitt Cancer Center, which is located just a short drive away in Tampa. Our Urologic Oncology Program features some of the most knowledgeable and experienced surgeons in the world, and we treat a high number of cancer patients every year, so we have the refined expertise needed to determine which treatments will yield the best quality of life for you.Â
The surgical teams at Moffitt are highly adept in every surgical approach, from traditional surgeries to the latest minimally invasive procedures. Known as a world leader in robot-assisted laparoscopic surgery, Moffitt has surgeons who are skilled in utilizing robotics to perform procedures in a nerve-sparing, minimally invasive fashion. As a result, we can often reduce recovery times, pain and complications related to surgery. When performing a cystoprostatectomy, a surgeon will generally remove the:Â
- Bladder
- Prostate
- Perivesical tissues
- Seminal tissues
In addition to a cystoprostatectomy, we can also provide any additional treatment that you require, such as radiation therapy, at one convenient location. Also, to make your visit from Orlando, FL, as easy as possible, we’ve partnered with several local hotels that meet or exceed our stringent infection control and hygiene standards. That way, you can rest easy knowing that you’ll have a safe place to stay while you receive treatment and recover.Â
We welcome cystoprostatectomy patients from the Orlando, FL, with and without referrals. To learn more about the treatment options that we offer, call 1-888-663-3488Â or fill out our form.
Bladder Cancer
- Adrenal Cancer
- Anal Cancer
- Appendiceal (Appendix) Cancer
- Astrocytoma
- Basal Cell Carcinoma
- Bladder Cancer
- Bone Metastasis
- Brain Cancer
- Brain Tumor
- Breast Cancer
- Cervical Cancer
- Cholangiocarcinoma (Bile Duct Cancer)
- Colon Cancer
- Colorectal Cancer
- Cutaneous T-Cell Lymphoma
- Ductal Carcinoma In Situ
- Endometrial (Uterine) Cancer
- Esophageal Cancer
- Gallbladder Cancer
- Gastrointestinal Carcinoid Tumor
- GIST (Gastrointestinal Stromal Tumor)
- Glioblastoma
- Head and Neck Cancer
- HER2 Positive Breast Cancer
- Hodgkin Lymphoma
- Inflammatory Breast Cancer
- Invasive Ductal Carcinoma
- Kidney (Renal Cell) Cancer
- Leukemia
- Liver (Hepatocellular) Cancer
- Low-Grade Glioma
-
Lung Cancer
- Signs and Symptoms
- Diagnosis
- Treatment
- FAQs
- Lung Cancer Early Detection Center
- Lung Cancer Screening and Surveillance Program
- Lung Nodules
- Lung Surveillance Clinic
- Metastatic Lung Cancer
- Recurrence
- Survival Rate
- Your Lung Cancer Specialists
- Lung and Thoracic Tumor Education (LATTE)
- Thoracic Clinic Updates
- Insurance & Financial Information
- Lymphomas (Hodgkin and Non-Hodgkin)
- Melanoma
- Meningioma
- Merkel Cell Carcinoma
- Mesothelioma
- Metastatic Breast Cancer
- Multiple Myeloma-Plasma Cell Tumor
- Myelodysplastic Syndromes (MDS)
- Neuroendocrine Tumor
- Neurofibromatosis
- Non-Hodgkin Lymphoma
- Oral Cavity (Mouth) Cancer
- Oral Cavity or Throat Cancer
- Osteosarcoma
- Ovarian Cancer
- Pancoast Tumor
- Pancreatic Cancer
- Penile Cancer
- Pituitary Adenoma
- Prostate Cancer
- Rectal Cancer
- Sarcoma
- Skin Cancer (Nonmelanoma)
- Skull Base Tumors
- Small Intestine Cancer
- Spinal Tumor
- Squamous Cell Carcinoma
- Stomach (Gastric) Cancer
- Testicular Cancer
- Throat Cancer
- Thymoma
- Thyroid Cancer
- Tongue Cancer
- Tracheal Cancer
- Triple Negative Breast Cancer
- Vaginal Cancer
- Vulvar Cancer